Download PDF
Semin Vasc Med 2003; 03(3): 255-260
DOI: 10.1055/s-2003-44461
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms

Mark Andrew Crowther
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Further Information

Publication History

Publication Date:
21 November 2003 (online)

    Permissions and Reprints

ABSTRACT

Oral anticoagulants prevent thrombosis however they are associated with bleeding. The risk of both bleeding and thrombosis is increased when the International Normalized Ratio (INR) is outside the desired therapeutic range. Hence, oral anticoagulants should be administered with the intention of maximizing the “time within the therapeutic range.” The frequency of INR values outside this range can be decreased by (1) warfarin initiation algorithms that guide initial therapy and (2) use of computerized systems to guide chronic warfarin therapy. This article reviews these techniques.

KEYWORDS

Warfarin initiation - dosing algorithms - computerized dosing - International Normalized Ratio

REFERENCES

  • 1 O'Reilly R A, Aggeler P M. Studies on coumarin anticoagulant drugs. Initiation of warfarin without a loading dose.  Circulation . 1968;  38 169-177
    PubMedGoogle Scholar
  • 2 Kovacs M, Cruickshank M, Wells P S. et al . Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease.  Haemostasis . 1999;  28 62-68
    PubMedGoogle Scholar
  • 3 Ansell J, Hirsh J, Dalen J. et al . Managing oral anticoagulant therapy.  Chest . 2001;  119 22S-38S
    CrossrefPubMedGoogle Scholar
  • 4 Hirsh J, Dalen J, Anderson D R. et al . Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Chest . 2001;  119 8S-21S
    CrossrefPubMedGoogle Scholar
  • 5 Harrison L, Johnston M, Massicotte M P, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy.  Ann Intern Med . 1997;  126 133-136
    PubMedGoogle Scholar
  • 6 Crowther M A, Ginsberg J, Kearon C. et al . A randomized trial comparing 5 mg and 10 mg warfarin loading doses.  Arch Intern Med . 1999;  159 46-48
    CrossrefPubMedGoogle Scholar
  • 7 Ageno W, Turpie A G. Exaggerated initial response to warfarin following heart valve replacement.  Am J Cardiol . 1999;  84 905-908
    CrossrefPubMedGoogle Scholar
  • 8 Gedge J, Orme S, Hampton K K, Channer K S, Hendra T J. A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.  Age Ageing . 2000;  29 31-34
    CrossrefPubMedGoogle Scholar
  • 9 Kovacs M J, Rodger M, Anderson D R. et al . Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.  Ann Intern Med . 2003;  138 714-719
    CrossrefPubMedGoogle Scholar
  • 10 Albers G W. Atrial fibrillation and stroke. Three new studies, three remaining questions.  Arch Intern Med . 1994;  154 1443-1448
    CrossrefPubMedGoogle Scholar
  • 11 Aspect Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group.  Lancet . 1994;  343 499-503
    PubMedGoogle Scholar
  • 12 Hylek E M, Singer D E. Risk factors for intracranial hemorrhage in outpatients taking warfarin.  Ann Intern Med . 1994;  120 897-902
    CrossrefPubMedGoogle Scholar
  • 13 Cannegieter S C, Rosendaal F R, Wintzen A R, van der Meer J F, Vandenbroucke J P, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves.  N Engl J Med . 1995;  333 11-17
    CrossrefPubMedGoogle Scholar
  • 14 SPIRIT Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.  Ann Neurol . 1997;  42 857-865
    CrossrefPubMedGoogle Scholar
  • 15 Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized trial.  Lancet . 1996;  348 633-638
    CrossrefPubMedGoogle Scholar
  • 16 Wilson R, James A H. Computer assisted management of warfarin treatment.  Br Med J . 1984;  289 422-424
    PubMedGoogle Scholar
  • 17 Wyld P J, West D, Wilson T H. Computer dosing in anticoagulant clinics-the way forward?.  Clin Lab Haematol . 1988;  10 235-236
    PubMedGoogle Scholar
  • 18 Ryan P J, Gilbert M, Rose P E. Computer control of anticoagulant dose for therapeutic management.  Br Med J . 1989;  299 1207-1209
    CrossrefPubMedGoogle Scholar
  • 19 Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin.  J Clin Pathol . 1993;  46 299-303
    CrossrefPubMedGoogle Scholar
  • 20 Ageno W, Turpie A G. A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy.  Thromb Res . 1998;  91 237-240
    CrossrefPubMedGoogle Scholar
  • 21 Poller L, Shiach C R, MacCallum P K. et al . Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.  Lancet . 1998;  352 1505-1509
    CrossrefPubMedGoogle Scholar
  • 22 Cromheecke M E, Levi M, Colly L P. et al . Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.  Lancet . 2000;  356 97-102
    CrossrefPubMedGoogle Scholar